Mark Bokhart

Mark Bokhart is an accomplished scientist currently serving as Scientist III at BioAgilytix since September 2022. Previously, Mark held the position of Scientist II/Project Lead at KBI Biopharma from March 2021 to September 2022, contributing to the delivery of integrated drug development and biomanufacturing services. Mark also worked at GlaxoSmithKline as an Investigator from November 2017 to March 2021, where support was provided for chemistry, manufacturing, and controls using advanced mass spectrometry techniques. Prior to these roles, Mark gained valuable experience as a Research and Teaching Assistant at North Carolina State University and as a Toxicology Research Assistant at the Michigan State University Veterinary Diagnostic Lab. Mark earned a Doctor of Philosophy (PhD) in Analytical Chemistry from North Carolina State University and a Bachelor of Science (B.S.) in Chemistry from Michigan State University.